Delivery Order SPE2DX15D8002-SPE2DX24F2WP4

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $2.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,467.31, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of 4565365894 ! YUVAFEM 10 MCG VAGINAL INSERT 18S. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which enables the...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYWG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Delivery Order under the DLA Troop Support Medical's ECAT Generation V Program, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including prescription medications, medical devices, vaccines, and other healthcare-related items. The contract...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYZV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract has a ceiling value of $11,519.50 and is structured as a firm fixed-price delivery order. It is not designated as a set-aside contract. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The company specializes in providing...
This federal contract award, identified as SPE2DB24D8001, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract falls under the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $2,468.17 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract, identified as SPE2DB24D8003|SPE2DB25FJTZF, has an ultimate completion date of March 14, 2025. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has an award value of $1,193.01 and a completion date of February 7, 2024. This award is not associated with a set-aside program and is a firm fixed-price delivery order contract. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical...
This federal contract award, identified as SPE2DB24D8001 and SPE2DB24FKYWA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract falls under the DLA Troop Support Medical's ECAT...
The federal contract award SPE2DB24D8001 to Dakota Drug, Inc., a self-certified small disadvantaged business, provides for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense through the Defense Logistics Agency (DLA) Troop Support Medical program. This single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, allows Dakota Drug, Inc. to supply a comprehensive range of critical medical items, including treatments...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001 and SPE2DB25FKZED, is a Delivery Order with a Firm Fixed Price pricing type. The contract has a ceiling value of $2,077.19 and an ultimate completion date of February 11, 2025. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S....
This contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The award, valued at $1,179.40, is a Firm Fixed Price Delivery Order against the company's existing Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00. This IDC is part of the DLA Troop Support...
  • SPE2DX15D8002
    Indefinite Delivery Contract
  • SPE2DX15D8002-SPE2DX24F2WP4
    Delivery Order

This federal contract award, with an ID of SPE2DX15D8002|SPE2DX24F2WP4, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is a delivery order valued at $2,054.23 for the supply of 4564804060 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product.

The contract is not set aside and is a firm fixed price arrangement. Dakota Drug, Inc. has been awarded an Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This latest award falls under the DLA Troop Support Medical's ECAT Generation V Program and has a performance period extending through June 5, 2024.

Generated 5/16/25, 11:57 AM